Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors

Dettagli Bibliografici
Autori principali: Ghazaly, E, Woodcock, V, Spilipoulou, P, Spiers, L, Moschandreas, J, Griffiths, L, Gnanaranjan, C, Harrison, D, Evans, T, Blagden, S
Natura: Conference item
Pubblicazione: Oxford University Press 2017
_version_ 1826286183963951104
author Ghazaly, E
Woodcock, V
Spilipoulou, P
Spiers, L
Moschandreas, J
Griffiths, L
Gnanaranjan, C
Harrison, D
Evans, T
Blagden, S
author_facet Ghazaly, E
Woodcock, V
Spilipoulou, P
Spiers, L
Moschandreas, J
Griffiths, L
Gnanaranjan, C
Harrison, D
Evans, T
Blagden, S
author_sort Ghazaly, E
collection OXFORD
description
first_indexed 2024-03-07T01:40:00Z
format Conference item
id oxford-uuid:9688423b-aae7-44a4-ab1e-9d6810c56801
institution University of Oxford
last_indexed 2024-03-07T01:40:00Z
publishDate 2017
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:9688423b-aae7-44a4-ab1e-9d6810c568012022-03-26T23:53:32ZInterim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumorsConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:9688423b-aae7-44a4-ab1e-9d6810c56801Symplectic Elements at OxfordOxford University Press2017Ghazaly, EWoodcock, VSpilipoulou, PSpiers, LMoschandreas, JGriffiths, LGnanaranjan, CHarrison, DEvans, TBlagden, S
spellingShingle Ghazaly, E
Woodcock, V
Spilipoulou, P
Spiers, L
Moschandreas, J
Griffiths, L
Gnanaranjan, C
Harrison, D
Evans, T
Blagden, S
Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title_full Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title_fullStr Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title_full_unstemmed Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title_short Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
title_sort interim pharmacokinetic pk and pharmacodynamic pd data from the first in human study of nuc 3373 a pyrimidine nucleotide analogue in patients with advanced solid tumors
work_keys_str_mv AT ghazalye interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT woodcockv interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT spilipouloup interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT spiersl interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT moschandreasj interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT griffithsl interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT gnanaranjanc interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT harrisond interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT evanst interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors
AT blagdens interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors